Clinical trial
Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With…
NCT00006264 · AIDS Malignancy Consortium, Other · Completed
Key facts
| NCT number | NCT00006264 |
|---|---|
| Title | Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma |
| Official title | A Phase II Trial Of Induction Therapy With Zidovudine, Interleukin-2, And Ganciclovir In The Treatment Of HIV Positive Primary Central Nervous System Lymphoma |
| Lead sponsor | AIDS Malignancy Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | aldesleukin, ganciclovir, zidovudine |
| Start date | Jul 1, 2000 |
| Primary completion | Mar 1, 2003 |
| Completion | Jul 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 3, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: